A. “Pharmacological Characterization of Memoquin, a Multi-Target Compound for the Treatment of Alzheimer’s Disease,” by Valeria Capurro, Perrine Busquet, Joao Pedro Lopes, Rosalia Bertorelli, Glauco Tarozzo, Maria Laura Bolognesi, Daniele Piomelli, Angelo Reggiani, and Andrea Cavalli (PLoS ONE 8(2): e56870. doi:10.1371/journal.pone.0056870, XML, HTML, and .pdf format, 8p.).
www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0056870
B. “Cerebral Neovascularization and Remodeling Patterns in Two Different Models of Type 2 Diabetes,” by Roshini Prakash, Maribeth Johnson, Susan C. Fagan, and Adviye Ergul (PLoS ONE 8(2): e56264. doi:10.1371/journal.pone.0056264, XML, HTML, and .pdf format, 11p.).
www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0056264
